The success of an embryo transfer program is measured by the number of calves born alive by female donor in a given period. The success is influenced by several factors related to the number of ovulations, fertilization rate, and embryo viability (Armstrong D 1993 Theriogenology 39, 7-24). One of the main inconveniences of embryo transfer programs is the variability of superovulatory response to treatments. An experiment was designed to determine the optimal dose of ovine pituitary gland extract Ovagen ® (ICPbio, Ltd., Auckland, New Zealand) for inducing superovulation in Aberdeen Angus donor cows. Sixty cycling multiparous donors with a condition score between 3.5 and 4.5 (Scale 1 to 5) were used. All donors received an intravaginal progesterone device DIB (1 g of Progesterone, Syntex, Buenos Aires, Argentina), along with 2 mg of EB (Estradiol Benzoate, Syntex, Buenos Aires, Argentina) and 50 mg of progesterone (Laboratorio Rio de Janeiro, Argentina) on Day 0. Superestimulatory treatment began on Day 4 and donors were randomly assigned to 3 treatment groups according to the total dose of NIADDK-oFSH-Z (Ovagen ® ) as follows: Group 1, cows received the total dose recommended by the manufacturer (100%* Group), 17.6 mg; Group 2, cows received 75% of the total dose recommended by manufacturer (75% Group), 13.2 mg and Group 3, cows received 50% of the total dose recommended by manufacturer (50% Group), 8.8 mg. All cows received two 150 µg of D+ cloprostenol IM (Ciclase, Syntex) injections on Day 6 given at 12 h interval. DIB was removed on Day 7 a.m. On Day 8 a.m., cows received 0.05 mg of GnRH IM (Gonasyn, Syntex). Fixed time AI was done on Day 8 p.m. and Day 9 a.m. with high quality frozen-thawed semen. On Day 15 embryo collection was performed by non-surgically method and evaluated by developmental stage and quality. The efficiency of superestimulatory response was evaluated by total amount of collected ova-embryos, fertilized ova and embryos Grade 1, 2, and 3, (according to IETS manual). One way AOV test was used to compare variables among groups and results are shown in Table 1 . A significant increase in total CL was observed for the groups receiving 75% or 100% of the recommended dose with respect to the group receiving 50% of that dose. There was also a significant greater number of grade 1 embryos for the groups receiving 75% or 100% of the dose than in the group receiving 50% of the recommended dose. There were no differences for any of the evaluated parameters between 75% and 100% dose groups. These results suggest that acceptable superstimulatory responses can be obtained using reduced doses of Ovagen ® in Aberdeen Angus donor cows. (*) the percentage makes reference to the total dose recommended by the laboratory of origin. .0 a ± 6.5 10.9 a ± 7.5 5.7 b ± 3.5 0.01 Fertilized 6.6 a ± 6.7 6.9 a ± 6.4 1.8 b ± 2.1 0.01 Ova 3.9 ± 3.8 3.0 ± 3. Although we have previously shown that superstimulation during the first follicular wave resulted in a successful response (Carballo Guerrero D et al. 2007 Reprod. Fertil. Dev. 20, 226), the protocol required many interventions that could influence its application in the field. Therefore, two studies
.0 a ± 6.5 10.9 a ± 7.5 5.7 b ± 3.5 0.01 Fertilized 6.6 a ± 6.7 6.9 a ± 6.4 1.8 b ± 2.1 0.01 Ova 3.9 ± 3.8 3.0 ± 3.3 2.0 ± 3.4 0.27 Grade 1 3.1 a ± 4.1 4.7 a ± 4.8 0.6 b ± 1.0 0.007 Grade 2 0.4 ± 1.1 0.0 ± 0.0 0.33 ± 0.59 0.29 Degenerate 2.4 ± 2.4 2.2 ± 2.5 0.9 ± 1.3 0.09 *(Average ± SD). Although we have previously shown that superstimulation during the first follicular wave resulted in a successful response (Carballo Guerrero D et al. 2007 Reprod. Fertil. Dev. 20, 226) , the protocol required many interventions that could influence its application in the field. Therefore, two studies were designed to simplify the superstimulation treatment protocol. Experiment 1 was designed to determine whether it was necessary to remove the progesterone releasing device during the superstimulation protocol. Angus cows (n = 37) were superstimulated by two treatments in a crossover design. Cows in Group 1 (control) received a progesterone releasing device (Cue-Mate, Bioniche Animal Health, Belleville, ON, Canada) along with 0.150 mg D cloprostenol (PGF, Bioprost-D, Biotay, Argentina) IM, at random stages of the estrous cycle. Five days later, a second PGF was injected and Cue-Mates were removed, followed by GnRH (0.050 mg Lecirelina, Biosin-OV, Biotay) 36 h later; ovulation was expected to occur 30 to 36 h later. On Day 0 (36 h after GnRH) donors received a new Cue-Mate and superstimulation treatment was initiated with a total dose of 400 mg NIH-FSH-P1 of Folltropin-V (FSH, Bioniche Animal Health) in twice daily decreasing doses over 5 days. PGF was injected with the last two FSH injections and Cue-Mates were removed with the last FSH injection. Cows in Group 2 were treated similarly to those in the control group, except that Cue-mate devices were not replaced and remained in place for 13 days (i.e. Cue-mates were removed with the last FSH and PGF injection). All donors received 12.5 mg pLH (Lutropin-V, Bioniche Animal Health) 24 h after Cue-Mate removal and were AI 12 and 24 h later. Embryos were collected 7 days after pLH. Means were compared between groups by Student's t-test. Superovulatory response and embryo production did not differ between groups. Mean (± SEM) number of ova/embryos collected and transferable embryos were 8.2 ± 1.0 and 4.1 ± 0.6 v. 9.8 ± 0.9 and 5.7 ± 0.7 for Groups 1 and 2, respectively (P > 0.2). Experiment 2 was designed to evaluate the effect of giving FSH for 4 v. 5 days. Simmental (n = 18) and Angus (n = 6) cows were superstimulated by the two treatment protocols in a crossover design. Cows in both groups were treated similarly to those in Group 2 in Experiment 1 (i.e. Cue-Mates were not replaced during treatment). Cows in Group 1 (control) received FSH over 5 days (as in Group 2 of Experiment 1); while those in Group 2 received the same dosage of FSH, but given in twice daily decreasing doses over 4 days (Cue-Mates were removed with the last FSH and PGF injections). Superovulatory response and embryo production did not differ among groups. Mean (± SEM) number of ova/embryos collected and transferable embryos were 13.5 ± 2.4 and 6.6 ± 1.1 v. 12.0 ± 1.9 and 5.8 ± 1.0 for Groups 1 and 2, respectively (P > 0.6). In conclusion, superstimulation of cattle at the time of emergence of the first follicular wave after ovulation results in an acceptable superovulatory response and all treatments evaluated were user-friendly and equally efficient.
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SUPEROVULATORY RESPONSE IN BEEF CATTLE TREATED DURING THE FIRST FOLLICULAR WAVE FOLLOWING SYNCHRONIZATION OF OVULATION WITH A PROGESTIN DEVICE AND GnRH
D. Carballo Guerrero
EFFECT OF A SINGLE INJECTION OF FSH DISSOLVED IN POLYETHYLENE GLYCOL ON SUPEROVULATION RESPONSE IN KOREAN NATIVE COWS
S. H. Choi, K. H. Cho, and Y. S. Park
Kyoungbuk National Livestock Research Institute, Yeongji, Gyeongbuk, Korea Superovulation in bovine is usually achieved after several FSH injection in a time-consuming protocol, and the half-life of FSH is very short. This study was carried out to assess the efficiency of embryo production after induction of superovulation with a single injection of FSH (Folltropin-V, Vetrepharm, Canada) dissolved in polyethylene glycol (PEG, 8000 MW, Sigma-Aldrich Corp., St. Louis, MO, USA) in Korean Native cows. Eightyeight cows were randomly assigned to one of four groups. In Group 1 (control), cows were intramuscularly treated with twice-daily administration of 50 mg FSH for 4 days. In Group 2 and 3, cows received a single subcutaneous injection of 400 mg and 200 mg FSH dissolved in 30% PEG, respectively. In Group 4, cows received a single subcutaneous injection of 200 mg FSH dissolved in 30% PEG given seven days after CIDR insertion. On days 10 to 12 after observed estrus, superovulation was started. Luteolysis was induced by administration of 25 mg of PGF2α (Pharmacia, Puurs, Belgium) IM 2 days after the start of the FSH injection. Donors were timed-inseminated with frozen-thawed semen at 48 and 60 h after the administration of PGF2α. Embryos were collected by non-surgical methods on 7 days after the second AI. The numbers of corpus lutea (CL), total ova, transferable embryos, and progesterone concentration were analyzed by General Linear Models Procedure with the Statistical Analysis System (SAS; SAS Institute, Inc., Cary, NC, USA) and means were compared with the Duncan's multiple range test. Data on the pregnancy rate was analyzed by chi-square test. P values <0.05 were considered to be significantly different. The number of CL in Group 2 was significantly (P < 0.05) higher compared to Groups 1, 3 and 4 (18.5 ± 7.5 v. 11.2 ± 5.1, 13.1 ± 5.1 and 13.9 ± 6.4, respectively). However, the number of total ova (7.9 ± 6.0 to 10.4 ± 7.2) and transferable embryos (3.7 ± 3.3 to 4.7 ± 3.9) did not differ among treatment groups. In addition, blood progesterone concentrations at embryo recovery did not differ among all groups (10.0 ± 3.5 ng mL −1 to 15.7 ± 3.2 ng mL −1 ). No difference was observed among groups in pregnancy rate after transferring the recovered embryos (36.0 to 50.0%). In conclusion, our results show that a single injection of FSH dissolved in polyethylene glycol is an efficient and simple procedure for inducing superovulation in Korean native cows. Follicle stimulating hormone (FSH) is usually administered in a series of intramuscular (IM) injections to induce multiple ovulations for embryo production in cattle and other species. The objective of this study was to determine the superovulatory response of dairy cows to subcutaneous (SC) administration of FSH using a reduced number of injections in combination with a progesterone-releasing device. Eighteen non-lactating Holstein cows initially received 25 mg Prostaglandin F 2α IM (PGF; Lutalyse; Pfizer Animal Health, Groton, CT, USA) on Day −7. All cows then received an intravaginal progesterone-releasing device (CIDR-B, 1.38 mg progesterone; Pfizer Animal Health) on Day 0, and 100 µg GnRH IM (Cystorelin; Merial Ltd, USA) on Day 2. Cows were randomly assigned to receive a total of 400 mg (20 mL) of FSH (Folltropin-V; Bioniche Animal Health, USA) either by IM injection (IM Group, n = 9 cows) given at 12 h intervals on Days 4 (60 mg, 60 mg), 5 (55 mg, 55 mg), 6 (45 mg, 45 mg) and 7 (40 mg, 40 mg), or by SC injection (SC Group, n = 9 cows) given at 24 h intervals on Days 4 (140 mg), 5 (140 mg) and Day 6 (120 mg). On Day 7, CIDR-B inserts were removed and cows received two 25 mg PGF IM injections given 12 h apart. Cows were artificially inseminated at 12
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and 24 h after standing estrus. Blood samples were obtained from all cows at 0, 2, 4, 8, 12, 24, 36, 48, 60, 72 , and 84 h after the first FSH injection for determination of serum FSH concentrations. Ovarian follicles and CL were monitored using ultrasonography on Days 4, 7, and 16. Embryos were recovered non-surgically on Day 16 (7 days after estrus). The effects of treatment on follicular response and embryo yield were analyzed by Wilcoxon test, and the response of cows to treatment was analyzed by chi-square test. The effects of treatment on concentrations of serum FSH were analyzed using ANOVA for repeated measures. There was no effect (P > 0.05) of route of FSH administration on the concentrations of serum FSH at any time point. The superovulatory response of cows to treatment, defined as greater than 2 CL per cow, did not differ (P > 0.05) between the IM (77.8%, 7/9 cows) and SC (88.9%, 8/9 cows) Groups. There was also no difference (P > 0.05) between the IM and SC Groups for the number of 5 to 10 mm follicles prior to FSH treatment (mean ± SEM; 0.6 ± 0.2 v. 0.9 ± 0.4), the total number of follicles after FSH treatment (12.4 ± 1.6 v. 12.7 ± 2.2) or the number of CL at embryo recovery (6.4 ± 1.5 v. 10.4 ± 2.1). Similarly, there were no differences (P > 0.05) between the IM and SC Groups for total number of oocytes/embryos (5.6 ± 2.6 v. 13.0 ± 4.3), transferable embryos (Grade 1, 2, 3; 3.0 ± 1.4 v. 6.1 ± 2.9) or Grade 1 embryos (2.9 ± 1.4 v. 4.3 ± 2.5). In conclusion, administration of FSH using 3 SC injections in combination with a progesterone-releasing device was an effective method for superovulation of Holstein cows. Sperm motility is known to affect fertilization; however, little is known about the relationship between frozen-thawed sperm motility and in vivo fertilization following superovulatory treatment. The objective of this study was to evaluate a sperm function test as potential predictors of embryo production following superovulatory treatment in cattle. Two to five batches of semen (Japanese black bull, n = 4, A to D) were diluted with egg york-citrate-glycerol in 0.5 mL plastic straws, and they were stored in liquid nitrogen until analyzed. Frozen-thawed spermatozoa were evaluated for motility {motile sperm concentration (MSC, million mL −1 ), progressive MSC (PMSC, million mL −1 ) and velocity (µm s −1 )} using a sperm quality analyzer for bulls (SQA-Vb, Medical Electronic Systems, Caesarea, Israel). Each sample of 20 µL aspirated into the disposable capillary, was inserted into SQA-Vb. Measurements were displayed within 75 s. Intra-assay CVs of MSC, PMSC, and velocity were 14.2, 7.3 and 7.5%, respectively. Inter-assey CVs of them were 13.5, 3.9 and 4.3% respectively. Superstimulated donors (Japanese black cows, n = 161) were artificially inseminated with one dose of frozen-thawed semen (bull A = 74, B = 46, C = 21 and D = 20). The proportion of transferable embryo (IETS grade 1 to 3) was examined on day 7 (day 0 = estrus). Data were analyzed using ANOVA followed by Scheffe multiple comparison test, and Fisher's z-transformation. MSC, PMSC and velocity values differed significantly among each bull. The values of bull A were much lower than those of the other bulls. The proportion of transferable embryos produced by bull A was significantly lower than that of other bulls (P < 0.05, Table 1 ). Correlations showed significant association between MSC and proportion of transferable embryos (r = 0.99, P < 0.01). We conclude that bovine sperm motility using a SQA-Vb is a useful predictor of embryo production following superovulatory treatment. Despite considerable progress in the understanding of ovarian follicular growth in cattle, the variable and unpredictable superovulatory response of donor animals is still a limiting factor to the success in the embryo transfer industry. One of the main factors affecting the outcome is the presence or absence of a dominant follicle at the time of gonadotropin treatment. It has been shown that the removal of the dominant follicle using ultrasound-guided aspiration before superovulation increases the number of ova and transferable embryos (Bungartz and Niemann 1994 J. Reprod. Fertil. 101, 581-593). Transrectal color Doppler sonography has been used to evaluate the blood flow in the ovarian artery and to test the ovarian blood flow in relation to ovarian response upon hormonal treatment for superovulation. It has been determined that blood flow parameters (BFV: blood flow volume, PI: pulsatility index) have only limited diagnostic value to predict the outcome of a superovulation treatment (Honnens et al. 2008 (Honnens et al. doi.org/10.1016 (Honnens et al. /j.anireprosci.2008 . The objective of the present study was to investigate the effect of dominant follicle ablation on the ovarian blood flow during superovulation related to the outcome. At Day 8 of the estrous cycle, the dominant follicle was removed in 16 animals (Group 1). In 12 animals, the dominant follicle was left intact (Group 2). All animals received an eCG (3000 I.U.) injection on Day 10, a PGF2α injection on Day 12 and were inseminated twice starting 48 h later. Ovarian blood flow was determined in all animals by investigating the left and right ovarian arteries on Days 8, 10 and 12 of the estrous cycle and on Day 6 p.i. using a Logiq Book XP (General Electrics, UK) equipped with a 7.5 MHz probe. Doppler analysis was carried out using Pixelflux software (Chameleon Software, Germany). The PI was measured as described recently (Honnens et al. 2008 (Honnens et al. doi.org/10.1016 (Honnens et al. /j.anireprosci.2008 ). On Day 7 p.i., ova/embryos were collected by standard non-surgical uterine flushing and classified according to the IETS guidelines. Similar results were obtained for the PI in group 1 on Day 8 (1.13 ± 0.08) and Day 10 (1.35 ± 0.09). A decrease (P ≤ 0.05) was measured at Day 12 (0.89 ± 0.07) and Day 6 p.i. (0.60 ± 0.06). In group 2, the PI remained constant until Day 12 (Day 8: 1.34 ± 0.11, Day 10: 1.43 ± 0.14, Day 12: 1.44 ± 0.12). At Day 6 p.i., the PI was significantly reduced (0.66 ± 0.09; P ≤ 0.05). Between both groups, a significant difference (P ≤ 0.05) was only detected at Day 12. More ova/embryos and transferable embryos (P ≤ 0.05) were recovered from group 1 (11.3 ± 1.6, 4.7 ± 0.9) compared to group 2 (4.8 ± 1.2, 1.9 ± 0.6). However, no significant relation (P > 0.05, Spearman) between the PI and the number total ova/embryos or the number of transferable embryos could be determined. These results show that removing the dominant follicle increases the number of embryos after superovulation. However, PI in general could not be used to predict the outcome of a superovulatory treatment.
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EFFECT OF SPERMATOZOA MOTILITY ON TRANSFERABLE EMBRYO RATE OF SUPEROVULATED JAPANESE BLACK CATTLE
K. Hayama A , M. Takeuchi A , A. Ideta A , M. Urakawa A , M. Sasatani B ,
DOPPLER SONOGRAPHY OF THE OVARIAN ARTERIES IN SUPEROVULATED CATTLE
Ä. Honnens
A,C , C. Klein A,C , K.-G. Hadeler C , H. Niemann C ,
EFFECT OF GnRH AND ESTRADIOL BENZOATE INJECTION ON SUPEROVULATORY RESPONSE IN EARLY POSTPARTUM SUCKLING JAPANESE BLACK COWS
K. Oshima, Y. Ochiai, T. Kojima, and N. Yamamoto
National Agricultural Research Center for Western Region, Oda, Shimane, Japan
The objective of this study was to investigate the effect of GnRH and EB injection on the SOV response in early postpartum suckling Japanese Black cows. Forty-eight cows were included in this study. All cows received a controlled internal-drug-releasing device containing 1.9 g progesterone (CIDR; Easi-Breed; InterAg, Hamilton, New Zealand) at 40 days postpartum, and were subsequently superstimulated with a total dose of 20 armour units FSH (Antrin 40; Kawasaki-Mitaka, Kanagawa, Japan) twice daily, with gradually decreasing doses from day 45 till day 47. CIDR was withdrawn with 0.75 mg of cloprostenol (Estrumate; Nagase Medicals, Itami, Japan) injection at day 47. After FSH treatment, the cows were assigned to 3 groups:
(1) 100 µg GnRH (Conceral; Nagase Medicals) injection at day 49 (GnRH, n = 19), (2) 2 mg EB (Kawasaki-Mitaka) injection at day 48 (EB, n = 15), and (3) control (n = 14). AI was carried out twice based on the estrous behavior of the cows, which was examined several times daily. Embryos were nonsurgically collected 7 to 8 days after estrus. The ovaries were examined by ultrasonography, and the number of CL and unovulated follicles (UF) were counted. After uterine flushing, the cows were re-employed for reproductive purposes. The intervals to first estrus after flushing and days open were examined. Blood samples were collected temporally, and concentrations of progesterone (P4) and estradiol (E2) were measured. The ovaries were examined by ultrasonography and the number of CL, small follicles (<5 mm in diameter), medium follicles (between 5 and 10 mm in diameter), and large follicles (>10 mm in diameter) were counted temporally. Data were analyzed by GLM and Dunnett's T3 test. There were no significant differences between both treatment groups and the control group in the number of CL (15.2 ± 6.8, 18.9 ± 9.4, and 14.9 ± 8.9 in the GnRH, EB, and control groups, respectively; mean ± SD), UF (5.3 ± 3.2, 4.7 ± 3.2, and 7.2 ± 9.5, respectively), recovered ova or embryos (11.4 ± 8.1, 11.1 ± 8.9, and 11.1 ± 9.1, respectively), transferable embryos (6.8 ± 5.3, 7.5 ± 7.6, 7.2 ± 6.7, respectively), and freezable embryos (6.3 ± 5.6, 6.6 ± 7.9, and 5.7 ± 6.1, respectively). Furthermore, there were no significant differences in the intervals to first estrus after flushing and days open (12.7 ± 13.6 and 90.0 ± 23.1 in the GnRH, 8.6 ± 5.3 and 79.1 ± 20.1 in the EB, and 9.4 ± 6.0 and 88.5 ± 33.8 in the control groups, respectively). Changes in the P4 level were similar among the 3 groups. The E2 level of the EB group at 15 h after EB injection was significantly higher (P < 0.05) than that in the other groups (19.0 ± 15.7, 49.4 ± 22.8, and 8.0 ± 5.7 pg mL −1 in the GnRH, EB, and control groups, respectively). The number of small follicles in the control group (17.0 ± 12.2) was significantly greater (P < 0.05) than that in the GnRH group (7.4 ± 7.2) at the first AI. These results suggest that EB and GnRH injection after SOV treatment in early postpartum Japanese Black cows does not affect the SOV response or embryo quality. Results from a previous experiment have shown that the replacement of pFSH by eCG on the last day of the superstimulatory treatment in Nelore (Bos indicus) cows resulted in a greater superovulatory (SOV) response as compared to the treatment exclusively with pFSH (Barros CM et al. 2008 Repr. Fertil. Dev. 20, 152 abst) . The aim of this study was to investigate if a similar approach would be beneficial for embryo production in nulliparous Nelore heifers. Forty heifers were randomly divided into two SOV groups: FSH Group: eight pFSH injections or FSH-eCG Group: six pFSH injections followed by two eCG injections. Each female received both treatments 65 days apart in a cross-over design. The SOV protocols consisted of an IM injection of 2 mg estradiol benzoate (Estrogin, Farmavet, São Paulo, Brazil) and insertion of an intravaginal progesterone releasing device (1.9 g progesterone, CIDR, Pfizer, Hamilton, New Zealand) on Day 0. On Day 4.5, the superstimulatory treatments (70 mg pFSH; Folltropin-V, Bioniche Animal Health; Belleville, ON, Canada) were initiated and given in decreasing doses of 28, 21, 14, and 7 mg twice a day, over a 4-day period. The FSH-eCG Group had the last two doses of pFSH replaced by two doses of 150 IU eCG (Folligon, Bioniche). At the time of the fifth and sixth injections of FSH, 25 mg dinoprost tromethamine (Lutalyse, Pfizer, Paulinia, Brazil) was injected IM. The CIDR was removed at the time of the seventh superstimulatory injection. Ovulation was induced with an IM injection of 0.05 mg GnRH (gonadorelin acetate; Gestran Plus; ARSA S.R.L., Buenos Aires, Argentina) 12 h after the last superstimulatory injection. All heifers were artificially inseminated with frozen/thawed semen from the same bull 12 and 24 h after GnRH. Seven days after the first AI, embryos/ova were recovered using a nonsurgical uterine flushing technique and classified according to IETS standards. To determine the superstimulatory (number of follicles ≥6 mm 12 h prior to GnRH) and SOV (number of ovulated follicles 48 h after GnRH, confirmed by CL number at the time of embryo collection) responses, transrectal ultrasonography was performed. Data were analyzed by paired t test and are presented as mean ± SEM. There was no difference between FSH and FSH-eCG groups regarding superstimulatory (23.2 ± 1.9 v. 22.3 ± 1.6 follicles ≥6 mm, P = 0.56) or SOV (15.2 ± 1.1 v. 17.5 ± 1.4 CL, P = 0.21) responses. Treatments were also similar for number of total embryos/ova (9.6 ± 0.9 v. 9.5 ± 1.0, P = 0.91), viable embryos (4.9 ± 0.7 v. 3.7 ± 0.5, P = 0.17), or degenerate embryos (3.0 ± 0.6 v. 4.3 ± 0.7, P = 0.10) recovered. Contrasting with the results using Nelore cows, the present study did not observe improvement on embryo production by replacing of the last two doses of pFSH by eCG in superstimulated heifers.
LACK OF IMPROVEMENT ON EMBRYO PRODUCTION BY THE REPLACEMENT OF THE LAST TWO DOSES OF pFSH BY eCG IN SUPERSTIMULATED NELORE HEIFERS
Financial support from CNPq, FAPESP, EMBRAPA and Pfizer of Brazil. Traditionally, successful superstimulation of cattle depended on initiating injections of gonadotrophin at mid-cycle, approximately at second follicular wave emergence.This approach limited the convenience of scheduling donors for superstimulation. With the use of intravaginal progesterone-releasing devices and estradiol 17β, superstimulation can be initiated successfully at any time of the estrous cycle. However, because estradiol cannot be legally injected into cattle in an increasing number of countries, the efficacy of GnRH as an estradiol substitute was investigated. A retrospective analysis was performed on data collected in a commercial bovine embryo transfer program over a period of several years. All donors were lactating dairy cows at least two years of age; approximately 75% were comprised of Holstein and the remainder of Jersey, Guernsey, or Brown Swiss breeds. The three treatments employed were (1) Controls injected twice daily for 4 days with a total of 240 to 400 mg of porcine FSH (Folltropin-V, Bioniche Animal Health, Inc.) in decreasing doses starting between day 7 and day 14 of diestrus, with PG (Lutalyse, Pfizer Animal Health) given at the time of FSH injections no. 5 (35 mg) and 6 (25 mg); (2) Estradiol females received a CIDR (Pfizer Animal Health), 5.0 mg estradiol 17β and 100 mg progesterone in oil on random days of the estrous cycle; FSH was initiated 4 days later as described for controls with CIDR removal at the time of FSH injection no. 6; (3) GnRH females received a CIDR on random days of the estrous cycle and 100 µg GnRH on day 1.5 following CIDR insertion; FSH was initiated 60 h after GnRH injection as described for controls with CIDR removal at the time of FSH injection no. 6. All donors were inseminated with one straw of frozen semen 12 and 24 h after the onset of estrus. Embryos were nonsurgically recovered 7 to 8 days after onset of estrus. Only embryos of grades 1 to 3 (IETS classification) were included in the data. Data were analyzed by ANOVA and Tukey's hsd test was used to distinguish significance among means as shown in Table 1 . Estradiol females produced approximately 2 more ova/embryos per procedure than Control and GnRH groups and an average of 0.8 more embryos per female than did the Control group, but there was no difference compared to the GnRH group. Similar to what has been shown in other commercial embryo transfer data sets, nearly 25% of the donors in each group failed to produce at least one good embryo. Clearly, all three treatments resulted in efficacious superstimulation. In light of the legality issues surrounding the use of estradiol, this study shows that GnRH can be used quite successfully to superstimulate dairy cattle at random times of the estrous cycle. 
COMPARISON OF THREE DIFFERENT PROTOCOLS FOR SUPERSTIMULATION OF DAIRY CATTLE
R. G. Steel
BIOACTIVE, BACTERIAL-DERIVED RECOMBINANT BOVINE FOLLICLE-STIMULATING HORMONE
M. E. Wilson, J. C. Morris, and J. R. Gibbons
Clemson University, Clemson, SC, USA Follicle-stimulating hormone is a pituitary-derived glycoprotein hormone comprising an α and β subunit produced from different genes. A suitable recombinant form of FSH is not readily available in the cattle industry, but would completely revamp current superovulation protocols and eliminate any opportunity for disease transmission. It is widely believed that post-translational glycosylations to the FSH molecule are important for in vivo half-life and must be present on the recombinant form to be most effective as a treatment. There is also speculation that this recombinant protein must be made in a tethered fashion to be most effective; furthermore, there is concern about which subunit must be engineered first in the fused product, and whether there should be some sort of linker sequence between the two subunits. The objective of this research was to produce a tethered, recombinant bovine FSH from Escherichia coli and evaluate its bioactivity compared with a marketed native FSH preparation. This recombinant protein has the β subunit fused upstream of the α subunit with no linker sequence. The pQE30 expression system was used to clone the desired gene, followed by protein expression induced by 1 m IPTG in M15pREP4 E. coli cells. The FSH protein was purified by using a C-terminal 6-histidine tag (provided by the pQE30 plasmid) in conjunction with nickel affinity chromatography. Subsequently, the Steelman-Pohley assay was used to evaluate bioactivity; briefly, 20-day-old Sprague-Dawley female rats were given 3 i.p. injections of a saline (used as a control), native, or bacterial recombinant FSH treatment every 24 h. Additionally, each treatment contained 50 µg of human chorionic gonadotropin. The 2 FSH treatments included the same amount of protein on a dry weight basis over the 3 injections adjusted for predicted FSH protein purity. Rats were sacrificed and ovaries were weighed 72 h after the first injection. Average ovarian weights were compared using a Student's t-test and significance was defined as P < 0.05 (see Table 1 ).
Results indicated that the recombinant FSH treatment group and the native FSH treatment group had heavier ovaries compared with the controls, but the recombinant FSH did not differ from the native FSH. Representative nonadjacent, midcortical ovarian histological sections (12 sections per treatment group) showed 5.6 ± 0.9, 11.3 ± 1.8, and 8.1 ± 1.6 antral follicles greater than 150 µm (mean ± SEM) for the control, recombinant FSH, and native FSH treatments, respectively; in addition, 0.8 ± 0.2, 1.2 ± 0.4, and 0.7 ± 0.2 corpa lutea were observed for the control, recombinant FSH, and native FSH treatments, respectively. These results suggest that a nonglycosylated bacterial-derived form of recombinant bovine FSH may be used to stimulate ovarian development in rats; however, more experiments must be conducted to evaluate in vivo half-life, bioactivity dynamics, and ultimately the capacity of this FSH preparation as a hyperstimulatory drug. Although various methodologies have been available for genetic modification in mouse, such genomic tools are very limited in rats. The aim of the present study was to take advantage of lentiviral gene delivery to develop effective inducible germline transgenic rats. A tetracycline inducible system was designed to control the expression of the green fluorescent protein (GFP) gene. The GFP gene was constructed downstream of tetracycline response element under the control of a mini cytomegalovirus promoter. Additionally, rtTA2s-Ms was constructed at the 3 prime terminus of GFP under the control of an ubiquitin promoter. The resulted construct was named pLV-Tet-GFP. The pLV-Tet-GFP lentiviral vectors were injected into perivitelline space of 115 Sprague-Dawley rat zygotes. Of those 115 zygotes injected, 93 zygotes were transferred into 4 surrogate mothers and 32 live pups were obtained. The presence of transgene in Fo generation was first detected by PCR and subsequently Southern blot analysis in 25 out of 32 pups (78%). A varying level of GFP expression was observed in the 14 Fo pups after feeding them with 2 g L −1 of tetracycline via drinking water for 4 days. Northern blot analysis was performed in the subsequent generations to determine spatial (brain, kidney, liver, and lung tissues) and temporal (day 0, day 4, day 11, and day 30) expression. The results showed expression intensity as being highest in kidney, brain, lung, and liver. There was little expression detected on day 11 and 30. This study suggests that lentiviral vectors can be used to deliver inducible system quite efficiently in rats.
